Startseite
Impressum
Datenschutz
 
 
  SPOT ON
 

ACCORD study - treatment guidelines for type 2 diabetes on trial

 
  NEW ON THE MARKET
 

Pneumococcal vaccines PREVENAR 13, SYNFLORIX

 
  READERS' QUESTIONS AND COMMENTS
 

Bipolar disorder: avoidable turnaround of EMA

 
  THERAPY FROM A CRITICAL VIEWPOINT
 

Diabetes prevention study NAVIGATOR

 
  IN BRIEF
 

Quality tests of oxycodone preparations

Recall of clopidogrel generics of Indian origin

Contamination of rota virus vaccine: avoid ROTARIX

Contraindication: Becaplermin (REGRANEX) and cancer

 
  CURRENT ADR NETWORK REPORT
 

Uzara root extract (UZARA) and facial oedema

 
  SIDE EFFECTS
 

Fatal renal failure due to bisphosphonate zoledronate

Non-prescription orlistat (ALLI): first establish on the market, then warn

 
© arznei-telegramm 4/2010